INS and type 2 diabetes mellitus: As expected, both insulin serum contents and mRNA expression levels increased significantly in T2DM mice treated with SENDs in comparison to the weak effect of metformin, especially after treatment with 5 mg kg−1 SENDs, which were 1.5‐fold and 3‐fold higher than those in T2DM, respectively (Figure 3E,F).